Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-07-09

Clinical Trial Update: Pre-Operative Pregabalin for Post-Operative Pain in Head and Neck Cancer Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating pre-operative pregabalin for postoperative pain in head and neck cancer surgery has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Augusta University | Conditions: Head and Neck Cancer, Pain, Postoperative | Phase 4 | Status: WITHDRAWN